JPH02242690A - Production of l-alanine - Google Patents
Production of l-alanineInfo
- Publication number
- JPH02242690A JPH02242690A JP6208889A JP6208889A JPH02242690A JP H02242690 A JPH02242690 A JP H02242690A JP 6208889 A JP6208889 A JP 6208889A JP 6208889 A JP6208889 A JP 6208889A JP H02242690 A JPH02242690 A JP H02242690A
- Authority
- JP
- Japan
- Prior art keywords
- alanine
- reaction
- aspartic acid
- acid
- decarboxylase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 15
- 229960005261 aspartic acid Drugs 0.000 claims abstract description 12
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims abstract description 10
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 235000004279 alanine Nutrition 0.000 claims abstract description 6
- 230000000813 microbial effect Effects 0.000 claims description 8
- 239000003125 aqueous solvent Substances 0.000 claims description 2
- 229960003767 alanine Drugs 0.000 abstract description 18
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract description 15
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract description 15
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 238000006911 enzymatic reaction Methods 0.000 abstract description 9
- 239000000243 solution Substances 0.000 abstract description 6
- 239000001530 fumaric acid Substances 0.000 abstract description 5
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007864 aqueous solution Substances 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 3
- 108090001066 Racemases and epimerases Proteins 0.000 abstract description 3
- 102000004879 Racemases and epimerases Human genes 0.000 abstract description 3
- 229910052799 carbon Inorganic materials 0.000 abstract description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract description 2
- 229910017053 inorganic salt Inorganic materials 0.000 abstract description 2
- 239000003456 ion exchange resin Substances 0.000 abstract description 2
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 238000000926 separation method Methods 0.000 abstract description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 241001227192 Pseudomonas dacunhae ATCC 21192 Species 0.000 abstract 1
- 230000002255 enzymatic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 108010041525 Alanine racemase Proteins 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical compound CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 description 1
- 239000001729 Ammonium fumarate Substances 0.000 description 1
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 1
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 239000001744 Sodium fumarate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000004716 alpha keto acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019297 ammonium fumarate Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- CKKXWJDFFQPBQL-SEPHDYHBSA-N azane;(e)-but-2-enedioic acid Chemical compound N.N.OC(=O)\C=C\C(O)=O CKKXWJDFFQPBQL-SEPHDYHBSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- MSJMDZAOKORVFC-SEPHDYHBSA-L disodium fumarate Chemical compound [Na+].[Na+].[O-]C(=O)\C=C\C([O-])=O MSJMDZAOKORVFC-SEPHDYHBSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019294 sodium fumarate Nutrition 0.000 description 1
- 229940005573 sodium fumarate Drugs 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、酵素法によるし−アラニンの製造法に間する
ものである。本発明によれば高収量で効率良くL−アラ
ニンを製造することが出来る。DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for producing alanine using an enzymatic method. According to the present invention, L-alanine can be efficiently produced with high yield.
L−アラニンは周知の如く、医薬、食品又は化学工業原
料として重要なアミノ酸であり、その需要が近年急激に
増加しつつある。As is well known, L-alanine is an important amino acid as a raw material for medicines, foods, or chemical industries, and its demand has been rapidly increasing in recent years.
(従来の技術と課題)
L−アスパラギン酸β−脱炭酸酵素を含有するシュード
モナス・ダクネー(Pseudomonas dacu
nl+ae)の菌体若しくはその破砕物の存在下し一ア
スパラギン酸を酵素反応させてL−アラニンを製造する
方法は、菌体内に存在するアラニンラセマーゼ活性によ
りL−アラニンがラセミ化する問題を有していた。(Prior art and problems) Pseudomonas dacu containing L-aspartate β-decarboxylase
The method of producing L-alanine by subjecting monoaspartic acid to an enzymatic reaction in the presence of microbial cells (nl+ae) or their crushed material has the problem that L-alanine is racemized by the alanine racemase activity present in the microbial cells. was.
また、L−アラニンを効率良く製造する為には、β−脱
炭酸酵素反応の反応速度を向上させることが重要となる
が、反応速度を向丘する為反応温度を上げた場合には菌
体内に存在するアラニンラセマーゼ活性も向上すること
が認められた。In addition, in order to efficiently produce L-alanine, it is important to improve the reaction rate of β-decarboxylase reaction, but if the reaction temperature is raised to increase the reaction rate, It was also observed that the alanine racemase activity present was improved.
かかる問題を解決すべく菌体の前処理によりアラニンラ
セマーゼ活性を除去する方法が提案されている(持閏昭
57−132882号公報、特間昭62−87088号
公報)が、菌体の前処理は煩雑であり、プロセスを出来
る限り簡素jこすることは製造コスト低減化に大きく影
響する為、本発明者らは、菌体の前処理を行うことなく
、高反応速度下でのL−アラニン生成反応中にラセマー
ゼ活性を抑ル1して効率良くL−アラニンを製造する方
法について鋭意検討した。その結果、反応を夜のl)H
を酸性域で、反応温度を40′C〜47℃に維持して酵
素反応することによりラセマーゼ活性を発現させること
なく、高収率でL−アラニンを製造可能なことを見い出
し本発明を完成するに到った。In order to solve this problem, a method has been proposed in which the alanine racemase activity is removed by pretreatment of the bacterial cells (Mochinan Sho 57-132882 Publication, Tokuma Sho 62-87088 Publication). is complicated, and simplification of the process as much as possible has a great effect on reducing manufacturing costs. Therefore, the present inventors developed a method for producing L-alanine at a high reaction rate without pretreating the bacterial cells. We have intensively investigated a method for efficiently producing L-alanine by suppressing racemase activity during the production reaction. As a result, the reaction at night l)H
The present invention has been completed by discovering that L-alanine can be produced in high yield without developing racemase activity by carrying out an enzymatic reaction in an acidic range while maintaining the reaction temperature at 40'C to 47C. reached.
(発明の構成及び効果)
本発明は、L−アスパラキン酸β−脱炭酸酵素活性を有
する微生物菌体又はその破砕物の存在下、水性溶媒中で
L−アスパラギン酸又はその塩を反応せしめ、該反応液
中に14−アラニンを生成するに際し、反応γαのI)
Hを4.3〜5.0且つ反応温度を40〜47℃に維
持することを特徴とするL−アラニンの製造方法を提供
するものである。(Structure and Effects of the Invention) The present invention involves reacting L-aspartic acid or a salt thereof in an aqueous solvent in the presence of microbial cells having L-aspartic acid β-decarboxylase activity or a crushed product thereof, When producing 14-alanine in the reaction solution, I) of reaction γα
The present invention provides a method for producing L-alanine, characterized in that H is maintained at 4.3 to 5.0 and the reaction temperature is maintained at 40 to 47°C.
(発明の詳細な説明)
本発明に使用する微生物としては、L−アスパラギン酸
β−脱炭酸酵素を含有するシュードモナス・ダクネー(
Pseudoo+onas dacur+hae) I
AM 1152が好適に用いられる。(Detailed Description of the Invention) The microorganism used in the present invention is Pseudomonas dacnae, which contains L-aspartate β-decarboxylase.
Pseudoo+onas dacur+hae) I
AM 1152 is preferably used.
本発明に用いられろ上記微生物菌体は、菌体のまま用い
ることも出来るし、超音波破砕等の処理により破砕した
破砕物も使用することが出来る。The above-mentioned microbial cells used in the present invention can be used as they are, or a crushed product obtained by crushing them by treatment such as ultrasonic crushing can also be used.
本発明の方法に使用される上記の微生物菌体の調製に使
用するIg地は、特に限定されるものではなく一般の微
生物に使用されるものでよい。The Ig source used for preparing the above-mentioned microbial cells used in the method of the present invention is not particularly limited, and may be one used for general microorganisms.
L−アスパラギン酸β−脱炭酸酵素を含有する微生物菌
体の1!I製に使用する培地の炭素源は、特に限定され
るものではなく、例えばフマル酸、コハク酸、リンゴ酸
、L−アスパラギン酸等が使用できるが、その中でもフ
マル酸が好適に使用される。培地の窒素源としては、ア
ンモニア、 硫酸アンモニウム、塩化アンモニウム、硝
酸アンモニウム、尿素等の無機塩を用いることが出来る
し、また、ペプトン、酵母エキス、コンスティープリカ
ー カザミノ酸等の有機栄養源も使用することが出来る
。無機塩としては、リン酸−水素カリウム、リン酸二水
素カリウム、硫酸マグネシウム等が用いられる。1 of microbial cells containing L-aspartate β-decarboxylase! The carbon source of the medium used for I production is not particularly limited, and for example, fumaric acid, succinic acid, malic acid, L-aspartic acid, etc. can be used, and among them, fumaric acid is preferably used. As a nitrogen source for the culture medium, inorganic salts such as ammonia, ammonium sulfate, ammonium chloride, ammonium nitrate, urea, etc. can be used, and organic nutrient sources such as peptone, yeast extract, consteep liquor, casamino acids, etc. can also be used. I can do it. As the inorganic salt, potassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, etc. are used.
培養は通気攪t′ト、振盪等の好気的条件下で行い、培
養温度は20℃〜40℃、好ましくは28℃〜32゛C
で1テう。培養途中のpHは5〜10、好ましくは7〜
8付近にて行い、培養中のp Hの調整には、酸又はア
ルカリを添加して行う。培養開始時の培地中の炭素源の
濃度は0.05〜10重量%が用いられ、具体例として
フマル酸を使用する場合、フマル酸濃度は、好ましくは
0. 1〜5重1%、更に好ましくは0.5〜2重量%
が適する。Cultivation is performed under aerobic conditions such as aeration and shaking, and the culture temperature is 20°C to 40°C, preferably 28°C to 32°C.
I'll take 1 te. pH during cultivation is 5-10, preferably 7-10.
The pH is adjusted to around 8.0 by adding acid or alkali to adjust the pH during culturing. The concentration of carbon source in the medium at the start of culture is 0.05 to 10% by weight, and when fumaric acid is used as a specific example, the fumaric acid concentration is preferably 0.05% to 10% by weight. 1-5% by weight, more preferably 0.5-2% by weight
is suitable.
培養肋間は10時間〜4日間、最適期間は1〜3日閏で
ある。Culture intercostals for 10 hours to 4 days, with an optimal period of 1 to 3 days.
このようにして得られた培養物から各々菌体を集めて、
水又は適当な緩衝液で洗浄し、本発明の酵素反応に使用
する。Collect bacterial cells from each culture obtained in this way,
It is washed with water or an appropriate buffer and used for the enzyme reaction of the present invention.
本発明の方法においては、上記で調製された微生物菌体
又はその破砕物の存在下、少なくともL−アスパラギン
酸又はその塩を含有する水溶液にて酵素反応させる。こ
こで該水溶液に添加されるL−アスパラギン酸又はその
塩の添加濃度は0゜5〜50M11に%、好ましくは3
〜30重量%である。なお、[、−アスパラギン酸は、
反応1夜への溶解度の関係から溶解させた状態でも粉体
で存在(不溶解状B)していてもさしつかえない。反応
液のpHの:JI整はアルカリ溶液、例えばアンモニア
水、水酸化ナトリウム、水酸化カリウム等が好適に使用
されろ。In the method of the present invention, an enzymatic reaction is carried out in an aqueous solution containing at least L-aspartic acid or a salt thereof in the presence of the microbial cells prepared above or a crushed product thereof. Here, the concentration of L-aspartic acid or its salt added to the aqueous solution is 0.5 to 50 M11%, preferably 3.
~30% by weight. In addition, [,-aspartic acid is
Due to the solubility during the reaction, it may exist in a dissolved state or as a powder (insoluble state B). To adjust the pH of the reaction solution, an alkaline solution such as aqueous ammonia, sodium hydroxide, potassium hydroxide, etc. is preferably used.
該水溶液には、さらにピリドキサール5′リン酸を0.
0005〜0.05重量%、好ましくは0.001〜0
.01重量%添加して用いることが出来る。さらに必要
な場合には非イオン性の界面活性剤、例えはポリオキシ
エチレンソルビタンモノオレエーi・、ポリオキシエチ
レンソルビタンモノラウレート等を0.01〜0. 5
重量%、好ましくは0.03〜0.2重量%を添加して
用いることが出来る。また必要な場合にはピルビン酸、
α−ケト酪酸等のα−ケト酸を0.0001〜0゜5
!Ii%、好マt、、<ハ0. 002〜0. 2mj
1%を添加して用いることが出来る。本発明において、
酵素反応時のpHは4.3〜5.0、好ましくは4.5
〜4.8であり、反応温度は40〜47℃、好ましくは
42〜45℃であり、反応は通常約3〜約48時間行わ
れる。The aqueous solution was further added with 0.0% pyridoxal 5' phosphoric acid.
0005-0.05% by weight, preferably 0.001-0
.. It can be used by adding 0.01% by weight. Furthermore, if necessary, a nonionic surfactant such as polyoxyethylene sorbitan monooleate i. 5
It can be used in an amount of 0.03 to 0.2% by weight, preferably 0.03 to 0.2% by weight. Also, if necessary, pyruvate,
α-keto acids such as α-ketobutyric acid from 0.0001 to 0°5
! Ii%, good mat,,<ha0. 002~0. 2mj
It can be used by adding 1%. In the present invention,
pH during enzyme reaction is 4.3 to 5.0, preferably 4.5
-4.8, the reaction temperature is 40-47°C, preferably 42-45°C, and the reaction is usually carried out for about 3 to about 48 hours.
上記のような反応方法によって得られる反応液中に生成
したL−アラニンの分離・精製は公知のイオン交喚樹脂
処理等により行うことが出来る。Separation and purification of L-alanine produced in the reaction solution obtained by the above reaction method can be carried out by a known ion exchange resin treatment or the like.
実験例
以下の実験例において、L−アラニンの定性はペーパー
クロマトグラフのRf値と高速液体クロマトグラフの保
持時間及び精製物の比旋光度により確認した。定量は、
高速液体クロマトグラフィー(島津LC−5A)を用い
て行った。Experimental Examples In the following experimental examples, the quality of L-alanine was confirmed by the Rf value on a paper chromatograph, the retention time on a high performance liquid chromatograph, and the specific rotation of the purified product. Quantification is
It was performed using high performance liquid chromatography (Shimadzu LC-5A).
D−アラニン生成量の定量は、豚の腎臓由来のD−アミ
ノ酸酸化酵素(ベーリンガー・マンハイムー山之内製薬
製)によりD−アラニンから生成するピルビン酸をヒド
ラゾンとして測定する方法により行った(Mett+o
ds in Enzymology、 vol、X V
U 、 Part A、 Edited by Her
bert Tabor and Ce1a White
Tabor、 Academic Press、 N
ew Vork、1970P、 17! −170
)。The amount of D-alanine produced was determined by measuring pyruvic acid produced from D-alanine as hydrazone using D-amino acid oxidase derived from pig kidney (manufactured by Boehringer Mannheim Yamanouchi Pharmaceutical Co., Ltd.).
ds in Enzymology, vol, XV
U, Part A, Edited by Her
bert Tabor and Ce1a White
Tabor, Academic Press, N.
ew Vork, 1970P, 17! -170
).
また、下記の実験例において%と表し°たのは重量%を
意味する。In addition, in the following experimental examples, % means weight %.
以下に実施例を挙げて本発明をさらに具体的に説明する
。The present invention will be explained in more detail with reference to Examples below.
実施例
(1〉微生物の調製
培地(フマル酸ナトリウム0.5%、フマル酸アンモニ
ウム1.0%、酵母エキス0. 5%、リン酸−カリウ
ム0.05%、M g S O4・7 H200,05
%含有、pH7,(1)looms!を500 mg容
三角フラスコに分注、滅菌した後シュードモナス・ダク
ネー(Pseudomonas dacunbae)J
AM 1152を植菌し、30℃にて1日間振盪培養を
行った(前培養)0次に、上記培地と同様の培地12を
22容通気攪拌槽に仕込み、滅菌(120℃、20分間
)後、前培養物の20 m 12を添加して、回転数1
00 Or p m、通気ffi 1 v v m、温
度30℃、り)17.3にて1日間培養を行った。Example (1) Preparation medium for microorganisms (sodium fumarate 0.5%, ammonium fumarate 1.0%, yeast extract 0.5%, potassium phosphate 0.05%, Mg SO4.7 H200, 05
% content, pH 7, (1) rooms! After dispensing into a 500 mg Erlenmeyer flask and sterilizing it, Pseudomonas dacunbae J
AM 1152 was inoculated and cultured with shaking at 30°C for 1 day (preculture).Next, a medium 12 similar to the above medium was charged into a 22 volume aerated stirring tank and sterilized (120°C, 20 minutes). After that, add 20 m 12 of preculture and rotate at 1 rpm.
Culture was carried out for 1 day at 00 Or p m, aeration ffi 1 v v m, temperature 30° C., and R) 17.3.
培養終了後、培養物100mRから遠心分離して集菌後
、該面体を0.9%NaC!溶液にて1回洗浄後、該洗
浄菌体を酵素反応に使用した。After culturing, the culture was centrifuged from 100 mR to collect bacteria, and the facepiece was washed with 0.9% NaC. After washing once with a solution, the washed bacterial cells were used for an enzyme reaction.
(2)実験方法
上記で得られた菌体を、第1表に示した実施区にて、水
性反応液[し−アスパラギン酸30%、ポリオキシエチ
レンソルビタンモノオレエート0.05%、ピリドキサ
ール5′−リン酸0.05%、ピルビン酸ソーダ0.0
2%含有、p I(調整はアンモニア水(25%NHJ
含有)にて行う]200 m 11に懸濁し、各温度で
5時間県盪した後の生成全アラニン量及び生成り一アラ
ニン屓を測定した。(2) Experimental method The bacterial cells obtained above were treated with an aqueous reaction solution [30% of aspartic acid, 0.05% of polyoxyethylene sorbitan monooleate, 5% of pyridoxal] in the experimental areas shown in Table 1. '-Phosphoric acid 0.05%, sodium pyruvate 0.0
Contains 2%, p I (adjusted with ammonia water (25% NHJ)
The total amount of alanine produced and the amount of alanine produced after suspension in 200 m 11 of water and shaking at each temperature for 5 hours were measured.
なお、対照として温度37゛C11)H5,5で反応さ
せた場合の全アラニン生成量及びD−アラニン生成量を
100とした。As a control, the total amount of alanine produced and the amount of D-alanine produced when the reaction was carried out at a temperature of 37°C11)H5.5 were set as 100.
(3)結果
結果は次の表に示す通りであり、本発明の方法により、
アラニンラセマーゼ活性を発現させることなくし一アス
パラギン酸β−・脱炭酸酵素の反応速度を高い状態で反
応させることが可能となった。(3) Results The results are shown in the following table, and by the method of the present invention,
It became possible to react monoaspartate β-decarboxylase at a high reaction rate without expressing alanine racemase activity.
Claims (1)
生物菌体又はその破砕物の存在下、水性溶媒中でL−ア
スパラギン酸又はその塩を反応せしめ、該反応液中にL
−アラニンを生成するに際し、反応液のpHを4.3〜
5.0且つ反応温度を40〜47℃に維持することを特
徴とするL−アラニンの製造法。(1) In the presence of microbial cells containing L-aspartate β-decarboxylase or a crushed product thereof, L-aspartic acid or its salt is reacted in an aqueous solvent, and L-aspartic acid or its salt is reacted in the reaction solution.
- When producing alanine, adjust the pH of the reaction solution to 4.3~
5.0 and maintaining the reaction temperature at 40 to 47°C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6208889A JP2832723B2 (en) | 1989-03-16 | 1989-03-16 | Method for producing L-alanine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6208889A JP2832723B2 (en) | 1989-03-16 | 1989-03-16 | Method for producing L-alanine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02242690A true JPH02242690A (en) | 1990-09-27 |
JP2832723B2 JP2832723B2 (en) | 1998-12-09 |
Family
ID=13189953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6208889A Expired - Lifetime JP2832723B2 (en) | 1989-03-16 | 1989-03-16 | Method for producing L-alanine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2832723B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149651A (en) * | 1990-04-27 | 1992-09-22 | Mitsubishi Petrochemical. Co., Ltd. | Process for culturing microorganisms of the genus pseudomonas and process for producing l-alanine using said microorganisms |
WO2010061890A1 (en) | 2008-11-27 | 2010-06-03 | 味の素株式会社 | Process for producing l-amino acid |
CN102605015A (en) * | 2011-01-20 | 2012-07-25 | 烟台恒源生物工程有限公司 | L-alanine production method |
CN113135832A (en) * | 2021-06-07 | 2021-07-20 | 秦皇岛华恒生物工程有限公司 | Comprehensive utilization method of microbial enzyme protein waste liquid |
-
1989
- 1989-03-16 JP JP6208889A patent/JP2832723B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5149651A (en) * | 1990-04-27 | 1992-09-22 | Mitsubishi Petrochemical. Co., Ltd. | Process for culturing microorganisms of the genus pseudomonas and process for producing l-alanine using said microorganisms |
WO2010061890A1 (en) | 2008-11-27 | 2010-06-03 | 味の素株式会社 | Process for producing l-amino acid |
CN102605015A (en) * | 2011-01-20 | 2012-07-25 | 烟台恒源生物工程有限公司 | L-alanine production method |
CN113135832A (en) * | 2021-06-07 | 2021-07-20 | 秦皇岛华恒生物工程有限公司 | Comprehensive utilization method of microbial enzyme protein waste liquid |
Also Published As
Publication number | Publication date |
---|---|
JP2832723B2 (en) | 1998-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2664648B2 (en) | Method for producing L-aspartic acid | |
JPH0559709B2 (en) | ||
JPS62289A (en) | Enzymatic production of l-alpha-amino acid from alpha-ketoic acid | |
JPH02242690A (en) | Production of l-alanine | |
US4492757A (en) | Process for preparing L-threonine | |
US5149651A (en) | Process for culturing microorganisms of the genus pseudomonas and process for producing l-alanine using said microorganisms | |
Çalık et al. | Growth and κ-carrageenan immobilization of Pseudomonas dacunhae cells for l-alanine production | |
JPH0347084A (en) | Production of l-alanine | |
Katagiri et al. | Studies on the Microbiological Production of Ketonic and Amino Acids (Commemoration Issue Dedicated to Professor Sankichi Takei On the Occasion of his Retirement) | |
JPH04197190A (en) | Production of l-alanine | |
JP2872178B2 (en) | Method for producing L-aspartic acid | |
JP2830029B2 (en) | Method of removing fumarase activity | |
JPH0591895A (en) | Production of d-serine | |
JPH037590A (en) | Production of l-alanine | |
JPS60120983A (en) | Culture of bacterial cell belonging to brevibacterium genus | |
JPS60156394A (en) | Preparation of l-2-amino-4-phenylbutyric acid | |
JPS6128398A (en) | Preparation of l-valine | |
JPH02207794A (en) | Removal of fumarase activity | |
JPS6363395A (en) | Production of l-phenylalanine | |
JPS58216692A (en) | Preparation of amino acid containing sulfur | |
JPS62289194A (en) | Production of phenylalanine or its derivative | |
JPS623792A (en) | Production of l-amino acid | |
JPS58209988A (en) | Preparation of sulfur-containing l-amino acid | |
JPH03266977A (en) | Incubation of beta-tyrosinase-containing microbe | |
JPS6062993A (en) | Preparation of l-serine |